PPA
BIOL

Parametric Portfolio Associates’s Biolase, Inc. BIOL Stock Holding History

Parametric Portfolio Associates’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2
Closed -$45K – 3344
2015
Q2 		$45K Hold
2
– – ﹤0.01% 3928
2015
Q1 		$63K Sell
2
-1
-33% -$28.3K ﹤0.01% 3902
2014
Q4 		$84K Hold
3
– – ﹤0.01% 3919
2014
Q3 		$80K Buy
+3
New +$84.8K ﹤0.01% 3745
2014
Q2 		– Sell
-3
Closed -$82K – 3801
2014
Q1 		$82K Buy
3
+1
+50% +$34.9K ﹤0.01% 3754
2013
Q4 		$72K Hold
2
– – ﹤0.01% 3754
2013
Q3 		$48K Buy
+2
New +$64.4K ﹤0.01% 3776

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Parametric Portfolio Associates's BIOL Position: Q3 2015 in Review

Parametric Portfolio Associates sold out of Biolase, Inc. (BIOL) in Q3 2015, closing a stake of 2 shares — an estimated $45K sold.

Parametric Portfolio Associates first reported a position in BIOL in Q3 2013 and held it in 7 quarters. The position peaked at $84K in Q4 2014. 32 funds tracked by Wall St. Rank hold BIOL as of Q3 2015.

  • Parametric Portfolio Associates reported no remaining Biolase, Inc. position as of Q3 2015 after selling out during the quarter.
  • Parametric Portfolio Associates sold 2 Biolase, Inc. shares in Q3 2015, an estimated $45K.
  • Parametric Portfolio Associates first reported a position in Biolase, Inc. in Q3 2013 and held it in 7 quarters.
  • Parametric Portfolio Associates's Biolase, Inc. position peaked at $84K in Q4 2014.
  • 32 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2015.

Based on Parametric Portfolio Associates's 13F filing for Q3 2015, filed 16 Nov 2015.